You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / HIKAL

HIKAL
Intrinsic Value | Fundamental Analysis

Returns | 1W : 3.9% , 1M : 15.8%,1Y : 64.7%
BOM : 524735     NSE : HIKAL    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 16,2021
Price(EOD): Rs. 179.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 2,214.47 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
HIKAL 3.9% 15.8% 64.7%
SUN PHARMACEUTICAL INDUSTRIES 1.4% 6.7% 41%
DR REDDYS LABORATORIES 2.8% 12.7% 27.3%
DIVIS LABORATORIES 1.9% 12.1% 58.1%
CIPLA 6.4% 16.6% 54.3%
BIOCON -1.8% 4.3% 20.1%
AUROBINDO PHARMA 1% 14.2% 77.7%
LUPIN -2.2% -0.5% 29.5%
TORRENT PHARMACEUTICALS 1.8% 7.7% 11.6%

FUNDAMENTAL ANALYSIS OF HIKAL

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than HIKAL Premium


VALUATION OF HIKAL

 
Valuation Score
RatioValue
P/E
P/B
P/S
26.22
P/E Calculated based on EPS of 6.85
[ Mar2020 - Standalone Results ]

2.71
P/B Calculated based on Book Value of 66.22
[ Mar2020 - Standalone Results ]

1.52
P/S Calculated based on Revenues of 1456.87 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than HIKAL Premium


FAIR VALUE OF HIKAL

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
25%
-1%
25%

SHARE PRICE MOMENTUM OF HIKAL

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.79
0.87
0.95
0.87
0.79
0.87
0.95
0.87
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
24.57%
29.86%
50.99%
49.46%
14.66%
20.65%
46.39%
42.03%
QtrlyTrend
8
Latest Qtr: Dec2020

HIKAL related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 1.2% 9.2% 53%
S&P BSE ALLCAP -1.9% -1.7% 68.2%
S&P BSE SMALL CAP -2.7% -0.4% 100.6%
S&P BSE MIDSMALLCAP -2.8% -0.8% 87.9%
No NSE index found

FAQ [Frequently Asked Questions]


Is HIKAL good for long term investment?

As on 16-Apr-2021, the Fundamentals of HIKAL are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of HIKAL . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is HIKAL UnderValued or OverValued?

As on 16-Apr-2021, HIKAL is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of HIKAL ?

As on 16-Apr-2021, the Intrinsic Value of HIKAL is Rs. 144.15 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 144.14
Fair Value [Median EV / Sales Model] : Rs. 181.30
Fair Value [Median Price / Sales Model] : Rs. 144.15
Median Fair Value of HIKAL : Rs. 144.15

Is HIKAL trading at a Premium or Discount?

As on 16-Apr-2021, HIKAL is trading at a Premium of 25% based on the Median Intrinsic Value!

Is it right time to buy HIKAL shares?

As on 16-Apr-2021, HIKAL is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of HIKAL?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with HIKAL?

HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
HIKAL LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z